Extending outbreak investigation with machine learning and graph theory: Benefits of new tools with application to a nosocomial outbreak of a multidrug-resistant organism.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
02 2023
Historique:
pubmed: 17 9 2022
medline: 17 2 2023
entrez: 16 9 2022
Statut: ppublish

Résumé

From January 1, 2018, until July 31, 2020, our hospital network experienced an outbreak of vancomycin-resistant enterococci (VRE). The goal of our study was to improve existing processes by applying machine-learning and graph-theoretical methods to a nosocomial outbreak investigation. We assembled medical records generated during the first 2 years of the outbreak period (January 2018 through December 2019). We identified risk factors for VRE colonization using standard statistical methods, and we extended these with a decision-tree machine-learning approach. We then elicited possible transmission pathways by detecting commonalities between VRE cases using a graph theoretical network analysis approach. We compared 560 VRE patients to 86,684 controls. Logistic models revealed predictors of VRE colonization as age (aOR, 1.4 (per 10 years), with 95% confidence interval [CI], 1.3-1.5; We identified risk factors for being a VRE carrier, along with 3 important links with VRE (healthcare personnel, medical devices, patient rooms). Data science is likely to provide a better understanding of outbreaks, but interpretations require data maturity, and potential confounding factors must be considered.

Identifiants

pubmed: 36111457
pii: S0899823X22000666
doi: 10.1017/ice.2022.66
pmc: PMC9929710
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

246-252

Références

J Hosp Infect. 2016 Nov;94(3):236-241
pubmed: 27645212
Curr Infect Dis Rep. 2019 May 22;21(7):22
pubmed: 31119397
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1457-1462
pubmed: 30394238
J Hosp Infect. 2019 Jan;101(1):69-75
pubmed: 30026006
PLoS One. 2020 Jul 7;15(7):e0235690
pubmed: 32634158
Clin Infect Dis. 2018 Jan 6;66(1):149-153
pubmed: 29020316
J Hosp Infect. 2018 Dec;100(4):e216-e225
pubmed: 29475013
Euro Surveill. 2022 Dec;27(48):
pubmed: 36695463
Microorganisms. 2019 Sep 26;7(10):
pubmed: 31561632
Sci Rep. 2019 Oct 15;9(1):14811
pubmed: 31616035
Clin Infect Dis. 2004 Oct 1;39(7):964-70
pubmed: 15472847
J Hosp Infect. 2018 Feb;98(2):202-211
pubmed: 28807836
Nat Microbiol. 2021 Jan;6(1):103-111
pubmed: 33106672
Infection. 2019 Feb;47(1):7-11
pubmed: 30178076
Ann Intern Med. 2002 Jun 4;136(11):834-44
pubmed: 12044132
Am J Epidemiol. 2019 Dec 31;188(12):2222-2239
pubmed: 31509183
Sci Rep. 2012;2:292
pubmed: 22379597
J Antimicrob Chemother. 2013 Apr;68(4):731-42
pubmed: 23208830
Euro Surveill. 2018 Jul;23(29):
pubmed: 30043725
PLoS One. 2017 Apr 25;12(4):e0176438
pubmed: 28441422
Antimicrob Resist Infect Control. 2021 Feb 18;10(1):38
pubmed: 33602300
Infect Control Hosp Epidemiol. 2016 Jan;37(1):26-35
pubmed: 26434609
Clin Microbiol Infect. 2020 Oct;26(10):1291-1299
pubmed: 32061798
Curr Infect Dis Rep. 2018 Apr 27;20(6):12
pubmed: 29704133
Infect Control Hosp Epidemiol. 2017 Feb;38(2):203-215
pubmed: 27825401
Microorganisms. 2020 Jan 31;8(2):
pubmed: 32024001

Auteurs

Andrew Atkinson (A)

Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Benjamin Ellenberger (B)

Insel Data Science Center, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Vanja Piezzi (V)

Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Tanja Kaspar (T)

Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Luisa Salazar-Vizcaya (L)

Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Olga Endrich (O)

Medical Directorate, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Alexander B Leichtle (AB)

Insel Data Science Center, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
University Institute of Clinical Chemistry, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.

Jonas Marschall (J)

Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH